Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-08-19
1988-10-04
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514215, 514216, 540473, 540582, 540583, C07D48704, A61K 3149
Patent
active
047756683
ABSTRACT:
Antibacterial compounds have the formula ##STR1## wherein R.sup.1 is hydrogen, a pharmaceutically aceptable cation, or alkyl; A is CH, CF, CCl or N; Y is alkyl, haloalkyl, cyclopropyl, vinyl, methoxy, N-methylamino, p-fluorophenyl, p-hydroxyphenyl or p-aminophenyl; or A is carbon and is taken together with Y and the carbon and nitrogen to which A and Y are attached to form a five to seven membered ring which is optionally substituted; and R.sup.2 is a bridged-diazabicycloalkyl group.
REFERENCES:
patent: 4146719 (1979-03-01), Irikura
patent: 4292317 (1981-09-01), Pesson
patent: 4382892 (1983-05-01), Hayakawa et al.
patent: 4448962 (1984-05-01), Irikura et al.
patent: 4499091 (1985-02-01), Wentland et al.
patent: 4571396 (1986-02-01), Hutt et al.
Jefson Martin R.
McGuirk Paul R.
Akers Lawrence C.
Hollrah Glennon H.
Holtrust Gezina
Pfizer Inc.
Richardson Peter C.
LandOfFree
Substituted bridged-diazabicycloalkyl quinolone carboxylic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted bridged-diazabicycloalkyl quinolone carboxylic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted bridged-diazabicycloalkyl quinolone carboxylic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2156514